Jyong Biotech Ltd. (MENS) — Institutional Holders, Q2 2026
19 institutional investment managers reported a MENS position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.0M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
MENS in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- HRT FINANCIALAdded · +38,656 sh+$80.0K
- XTX Topco LtdNew · +29,066 sh+$60.2K
- RENAISSANCE TECHNOLOGIESNew · +22,900 sh+$47.4K
- State of WyomingNew · +11,208 sh+$23.2K
- GEODE CAPITAL MANAGEMENTAdded · +4,650 sh+$9.6K
Biggest sellers
- UBS Group AGTrimmed · -33,317 sh-$69.0K
- MILLENNIUM MANAGEMENTSold out · -14,590 sh-$30.2K
- Vanguard Personalized Indexing ManagementSold out · -13,927 sh-$28.8K
- Tower Research Capital (TRC)Trimmed · -10,633 sh-$22.0K
- China Universal Asset Management , Ltd.Trimmed · -1,073 sh-$2.2K
MENS 13F holders ranked 1–19 of 19
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | BlackRock#1 · 260,317 sh | 260,317 | $538.9K | 0.00% | +0.6% |
| 2 | GEODE CAPITAL MANAGEMENT#2 · 68,882 sh | 68,882 | $142.6K | 0.00% | +7.2% |
| 3 | HRT FINANCIAL#3 · 50,423 sh | 50,423 | $104.0K | <0.01% | +328.5% |
| 4 | XTX Topco Ltd#4 · 29,066 sh | 29,066 | $60.2K | <0.01% | New |
| 5 | RENAISSANCE TECHNOLOGIES#5 · 22,900 sh | 22,900 | $47.4K | <0.01% | New |
| 6 | China Universal Asset Management , Ltd.#6 · 12,100 sh | 12,100 | $25.0K | — | -8.1% |
| 7 | State of Wyoming#7 · 11,208 sh | 11,208 | $23.2K | <0.01% | New |
| 8 | MORGAN STANLEY#8 · 6,112 sh | 6,112 | $12.7K | 0.00% | -3.0% |
| 9 | BARCLAYS PLC#9 · 5,931 sh | 5,931 | $12.3K | 0.00% | +14.3% |
| 10 | JPMORGAN CHASE#10 · 5,379 sh | 5,379 | $11.8K | 0.00% | -5.3% |
| 11 | UBS Group AG#11 · 4,046 sh | 4,046 | $8.4K | 0.00% | -89.2% |
| 12 | Mirae Asset Global Investments , Ltd.#12 · 3,400 sh | 3,400 | $7.0K | 0.00% | -12.2% |
| 13 | BNP PARIBAS FINANCIAL MARKETS#13 · 2,710 sh | 2,710 | $5.6K | 0.00% | +44.1% |
| 14 | CITIGROUP#14 · 2,501 sh | 2,501 | $5.2K | 0.00% | -10.3% |
| 15 | GF FUND MANAGEMENT LTD.#15 · 1,559 sh | 1,559 | $3.2K | — | -7.0% |
| 16 | Tower Research Capital (TRC)#16 · 1,070 sh | 1,070 | $2.2K | <0.01% | -90.9% |
| 17 | Cornerstone Financial Management#17 · 234 sh | 234 | $484.00 | <0.01% | New |
| 18 | Bell Investment Advisors#18 · 206 sh | 206 | $427.00 | <0.01% | -56.4% |
| 19 | Caitong International Asset Management , Ltd#19 · 9 sh | 9 | $19.00 | 0.00% | New |
Funds that sold out of MENS in Q2 2026 (3)
Held MENS at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| MILLENNIUM MANAGEMENT14,590 sh | 14,590 | $31.4K |
| Vanguard Personalized Indexing Management13,927 sh | 13,927 | $29.9K |
| ROYAL BANK OF CANADA266 sh | 266 | $1.0K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.